INS and obesity due to melanocortin 4 receptor deficiency: Height SDSs, BMI percentile and proportion of obesity between T1DM with or without using bolus insulin at tea-time did not differ significantly (−0.20 (1.23) vs. −0.42 (1.80), 58.1 (25.8) vs. 58.3 (24.5) and 0.0% vs. 1.8% in 2000; 0.04 (1.07) vs. 0.06 (1.09), 58.6 (25.8) vs. 56.5 (26.7) and 18.4% vs. 20.1% in 2008; 0.17 (1.07) vs. 0.17 (0.89), 59.2 (26.3) vs. 57.4 (25.5) and 28.0% vs. 26.5% in 2013, respectively).